Breaking News Instant updates and real-time market news.

LMAT

LeMaitre

$24.00

-0.2 (-0.83%)

07:06
03/21/17
03/21
07:06
03/21/17
07:06

LeMaitre initiated with an Overweight at First Analysis

First Analysis analyst Joseph Munda started LeMaitre with an Overweight rating and $29 price target, saying he expects the maker of peripheral vascular disease treatments to grow revenue at an 8-10% annual rate organically with additional growth from acquisitions and strong profitability.

  • 29

    Mar

LMAT LeMaitre
$24.00

-0.2 (-0.83%)

12/20/16
ROTH
12/20/16
NO CHANGE
Target $26
ROTH
Buy
LeMaitre price target raised to $26 from $21.50 at Roth Capital
Roth Capital analyst Chris Lewis raised his price target for LeMaitre to $26 from $21.50 to reflect the company's acquisition of Restore Flow Allografts. The analyst believes Restore's cryopreserved allograft offering is a nice fit to LeMaitre's expanding biologics product portfolio and expects the latter to be able to leverage its "strong" direct sales channel focusing solely on the vascular surgeon. He reiterates a Buy rating on LeMaitre's shares.
02/22/17
BRRR
02/22/17
DOWNGRADE
BRRR
Market Perform
LeMaitre downgraded to Market Perform from Outperform at Barrington
Barrington analyst Michael Petusky downgraded LeMaitre Vascular to Market Perform saying the shares are likely to "take a pause" now that the company's beat-and-raise streak is broken.
02/22/17
ADAM
02/22/17
NO CHANGE
Target $27
ADAM
Buy
LeMaitre pullback would be buying opportunity, says Canaccord
Canaccord analyst Jason Mills raised his price target on Lemaitre following mixed Q4 results and he said he would be constructive on any pullback in the shares. He said company guidance suggests business remains solid and would look to put new money to work on any Q4 driven pullbacks in the stock. Mills reiterated his Buy rating and raised his price target to $27 from $25 on LeMaitre shares.
02/22/17
ROTH
02/22/17
NO CHANGE
Target $26
ROTH
Buy
Roth Capital remains a buyer of LeMaitre after results
Roth Capital analyst Chris Lewis notes that LeMaitre's light Q4 was surprising considering its recent string of beat and raise quarters. Nonetheless, the analyst says that his thesis on LeMaitre, which is founded on above average top-line growth, expanding margins/profitability, and a strong balance sheet/cash flow to support accretive M&A, remains intact. Lewis is confident in the company's ability to deliver sustainable 10% revenue growth and 20% operating income growth, as the 2017 guidance implies. He reiterates a Buy rating and $26 price target on the shares.

TODAY'S FREE FLY STORIES

FBC

Flagstar Bancorp

$30.09

0.15 (0.50%)

06:42
07/25/17
07/25
06:42
07/25/17
06:42
Earnings
Flagstar Bancorp reports Q2 EPS 71c, consensus 61c »

Reports Q2 book value per…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

  • 01

    Aug

  • 11

    Aug

MFG

Mizuho Financial Group

06:41
07/25/17
07/25
06:41
07/25/17
06:41
Hot Stocks
Mizuho Securities to proceed with application for establishing EU subsidiary »

Mizuho Securities Co., a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CPLA

Capella Education

$88.05

0.1 (0.11%)

06:41
07/25/17
07/25
06:41
07/25/17
06:41
Earnings
Capella Education reports Q2 cont ops EPS 90c, consensus 80c »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

PLYM

Plymouth Industrial REIT

$17.35

0.2475 (1.45%)

06:39
07/25/17
07/25
06:39
07/25/17
06:39
Hot Stocks
Plymouth Industrial REIT to acquire Airport Business Park in Memphis for $7.8M »

Plymouth Industrial REIT…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NTES

NetEase

$311.50

4.3 (1.40%)

06:38
07/25/17
07/25
06:38
07/25/17
06:38
Recommendations
NetEase analyst commentary  »

NetEase price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Aug

AXE

Anixter

$78.85

0.5 (0.64%)

06:37
07/25/17
07/25
06:37
07/25/17
06:37
Hot Stocks
Anixter sees FY17 organic sales growth up 3.0%-5.0% »

The company said,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

CIT

CIT Group

$48.90

-0.09 (-0.18%)

06:36
07/25/17
07/25
06:36
07/25/17
06:36
Earnings
CIT Group reports Q2 operating EPS ex-items 68c, consensus 60c »

Reports Q2 revenue $605M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

TSLA

Tesla

$342.52

14.12 (4.30%)

, FB

Facebook

$166.00

1.57 (0.95%)

06:36
07/25/17
07/25
06:36
07/25/17
06:36
Hot Stocks
Musk says Zuckerberg's knowledge of artificial intelligence 'limited' »

In response to a tweet…

TSLA

Tesla

$342.52

14.12 (4.30%)

FB

Facebook

$166.00

1.57 (0.95%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jul

  • 02

    Aug

  • 08

    Aug

  • 13

    Sep

  • 02

    Oct

BIIB

Biogen

$284.70

1.78 (0.63%)

06:36
07/25/17
07/25
06:36
07/25/17
06:36
Hot Stocks
Biogen announces updated strategic framework »

Biogen announced an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

  • 01

    Aug

VLKAY

Volkswagen

$32.19

-0.79 (-2.40%)

, POAHY

Porsche

$5.82

-0.03 (-0.51%)

06:35
07/25/17
07/25
06:35
07/25/17
06:35
Periodicals
VW CEO criticizes Porsche labor chief's remarks on Audi, Reuters says »

Volkswagen (VLKAY) CEO…

VLKAY

Volkswagen

$32.19

-0.79 (-2.40%)

POAHY

Porsche

$5.82

-0.03 (-0.51%)

AUDVF

Audi AG

$835.60

-4.8 (-0.57%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AXE

Anixter

$78.85

0.5 (0.64%)

06:35
07/25/17
07/25
06:35
07/25/17
06:35
Earnings
Anixter reports Q2 adjusted EPS $1.36, consensus $1.34 »

Reports Q2 revenue $2.0B,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

AEL

American Equity

$28.06

0.06 (0.21%)

06:34
07/25/17
07/25
06:34
07/25/17
06:34
Downgrade
American Equity rating change  »

American Equity…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Aug

TRMB

Trimble

$38.20

0.49 (1.30%)

06:34
07/25/17
07/25
06:34
07/25/17
06:34
Hot Stocks
Trimble adds first partner in Latin America to Vantage network »

Trimble announced that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Aug

  • 02

    Aug

  • 14

    Aug

SVU

Supervalu

$3.25

-0.01 (-0.31%)

06:33
07/25/17
07/25
06:33
07/25/17
06:33
Hot Stocks
Supervalu sees FY18 net earnings from continuing operations $51M-$70M »

Sees FY18 adjusted…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

BIIB

Biogen

$284.70

1.78 (0.63%)

06:33
07/25/17
07/25
06:33
07/25/17
06:33
Earnings
Biogen raises FY17 adjusted EPS view to $20.80-$21.40 from $20.45-$21.25 »

FY17 consensus $20.38.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

  • 01

    Aug

GPK

Graphic Packaging

$13.77

0.04 (0.29%)

06:33
07/25/17
07/25
06:33
07/25/17
06:33
Earnings
Graphic Packaging reports Q2 adj. EPS 15c, consensus 15c »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

PHM

PulteGroup

$24.42

0.11 (0.45%)

06:32
07/25/17
07/25
06:32
07/25/17
06:32
Hot Stocks
Breaking Hot Stocks news story on PulteGroup »

PulteGroup believes…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

SVU

Supervalu

$3.25

-0.01 (-0.31%)

06:32
07/25/17
07/25
06:32
07/25/17
06:32
Earnings
Supervalu reports Q1 adjusted EPS 9c, consensus 11c »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

MORE

Monogram Residential Trust

$11.95

0.01 (0.08%)

06:32
07/25/17
07/25
06:32
07/25/17
06:32
Downgrade
Monogram Residential Trust rating change  »

Monogram Residential…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PHM

PulteGroup

$24.42

0.11 (0.45%)

06:32
07/25/17
07/25
06:32
07/25/17
06:32
Earnings
PulteGroup reports Q2 adjusted EPS 47c, consensus 41c »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

TEAM

Atlassian

$36.41

0.66 (1.85%)

06:31
07/25/17
07/25
06:31
07/25/17
06:31
Upgrade
Atlassian rating change  »

Atlassian upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Aug

BIIB

Biogen

$284.70

1.78 (0.63%)

06:31
07/25/17
07/25
06:31
07/25/17
06:31
Earnings
Biogen reports Q2 adjusted EPS $5.04, consensus $4.41 »

Reports Q2 revenue $3.1B,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

  • 01

    Aug

GOOG

Alphabet

$980.34

7.42 (0.76%)

, GOOGL

Alphabet Class A

$998.31

4.47 (0.45%)

06:30
07/25/17
07/25
06:30
07/25/17
06:30
Recommendations
Alphabet, Alphabet Class A analyst commentary  »

Alphabet earnings…

GOOG

Alphabet

$980.34

7.42 (0.76%)

GOOGL

Alphabet Class A

$998.31

4.47 (0.45%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LLY

Eli Lilly

$84.74

0.08 (0.09%)

06:30
07/25/17
07/25
06:30
07/25/17
06:30
Hot Stocks
Eli Lilly will pursue new standard-of-care changing therapies in oncology »

Eli Lilly is providing an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

  • 11

    Sep

LLY

Eli Lilly

$84.74

0.08 (0.09%)

06:29
07/25/17
07/25
06:29
07/25/17
06:29
Earnings
Eli Lilly raises FY17 EPS view to $4.10-$4.20 from $4.05-$4.15, consensus $4.12 »

Raises FY17 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

  • 11

    Sep

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.